Arrowhead Pharmaceuticals (UK) Analysis
| 0HI3 Stock | 26.51 0.21 0.80% |
Arrowhead Pharmaceuticals Corp is overvalued with Real Value of 20.43 and Hype Value of 26.5. The main objective of Arrowhead Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Arrowhead Pharmaceuticals Corp is worth, separate from its market price. There are two main types of Arrowhead Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Arrowhead Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Arrowhead Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Arrowhead Pharmaceuticals stock is traded in UK on London Exchange, with the market opening at 08:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in UK. Arrowhead Pharmaceuticals is usually not traded on Summer Bank Holiday, Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, May Day Bank Holiday, Spring Bank Holiday ( 2025 ). Arrowhead Stock trading window is adjusted to Europe/London timezone.
Arrowhead |
Arrowhead Stock Analysis Notes
About 80.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 1.08. Arrowhead Pharmaceuticals had not issued any dividends in recent years. For more info on Arrowhead Pharmaceuticals Corp please contact Christopher Anzalone at 626 304 3400 or go to https://arrowheadpharma.com.Arrowhead Pharmaceuticals Investment Alerts
| Arrowhead Pharmaceuticals had very high historical volatility over the last 90 days | |
| Arrowhead Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 3.55 M. Net Loss for the year was (609.69 M) with profit before overhead, payroll, taxes, and interest of 240.74 M. | |
| Arrowhead Pharmaceuticals generates negative cash flow from operations | |
| Over 80.0% of the company shares are owned by institutions such as pension funds | |
| Latest headline from news.google.com: Arrowhead Pharmaceuticals Inc. Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts - Yahoo Finance |
Arrowhead Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 255.82 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arrowhead Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Arrowhead Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Management Efficiency
Arrowhead Pharmaceuticals has return on total asset (ROA) of (0.4072) % which means that it has lost $0.4072 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.5184) %, meaning that it generated substantial loss on money invested by shareholders. Arrowhead Pharmaceuticals' management efficiency ratios could be used to measure how well Arrowhead Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Arrowhead Pharmaceuticals' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 466.5 M in 2024, whereas Other Assets are likely to drop slightly above 137.8 K in 2024.Leadership effectiveness at Arrowhead Pharmaceuticals Corp is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin (27.85) | Beta 0.934 | Return On Assets (0.41) | Return On Equity (1.52) |
Technical Drivers
As of the 30th of November, Arrowhead Pharmaceuticals shows the Downside Deviation of 3.26, mean deviation of 2.74, and Risk Adjusted Performance of 0.0575. Arrowhead Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Arrowhead Pharmaceuticals variance, jensen alpha, and the relationship between the standard deviation and information ratio to decide if Arrowhead Pharmaceuticals is priced correctly, providing market reflects its regular price of 26.51 per share.Arrowhead Pharmaceuticals Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Arrowhead Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Arrowhead Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Arrowhead Pharmaceuticals Predictive Daily Indicators
Arrowhead Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Arrowhead Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Arrowhead Pharmaceuticals Forecast Models
Arrowhead Pharmaceuticals' time-series forecasting models are one of many Arrowhead Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Arrowhead Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Arrowhead Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Arrowhead Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Arrowhead shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Arrowhead Pharmaceuticals. By using and applying Arrowhead Stock analysis, traders can create a robust methodology for identifying Arrowhead entry and exit points for their positions.
Arrowhead Pharmaceuticals is entity of United Kingdom. It is traded as Stock on LSE exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Arrowhead Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Additional Tools for Arrowhead Stock Analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.